Capricorn Fund Managers’s Amicus Therapeutics FOLD Stock Holding History

Capricorn Fund Managers’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-534,079	Closed	-$7.72M	–	190
2026 Q1	$7.72M	Buy	534,079 +323,405	+154%	+$4.64M	1.2%	32
2025 Q4	$3M	Buy	+210,674	New	+$2.07M	0.72%	50

Other funds holding FOLD

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Capricorn Fund Managers's FOLD Position: Q2 2026 in Review

Capricorn Fund Managers sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 534,079 shares — an estimated $7.72M sold.

Capricorn Fund Managers first reported a position in FOLD in Q4 2025 and held it in 2 quarters. The position peaked at $7.72M in Q1 2026. 1 fund tracked by Wall St. Rank holds FOLD as of Q2 2026.

Capricorn Fund Managers reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
Capricorn Fund Managers sold 534,079 Amicus Therapeutics shares in Q2 2026, an estimated $7.72M.
Capricorn Fund Managers first reported a position in Amicus Therapeutics in Q4 2025 and held it in 2 quarters.
Capricorn Fund Managers's Amicus Therapeutics position peaked at $7.72M in Q1 2026.
1 fund tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Capricorn Fund Managers's 13F filing for Q2 2026, filed 24 Jul 2026.